F. Kiweewa

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

P. Easterbrook, T. Peto, N. French, 2017, The lancet. HIV.

Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa

J. Baeten, K. Bunge, F. Martinson, 2021, BMC Women's Health.